Prospective Reassessment of the Association Between Pro-Inflammatory Factors and Prognosis After on-Pump Cardiac Surgery

Aim. Elevated levels of pro-inflammatory factors in plasma have been linked to worse prognosis after on-pump cardiac surgery, yet interventions that reduce the levels in patients have failed to improve prognosis. Therefore, we explored whether levels of pro-inflammatory factors are associated with prognosis of patients after valve surgery with cardiopulmonary bypass.
Material and methods. 244 patients were prospectively enrolled into observational study. Levels of tumor necrosis factor (TNF) – α, interleukin-8 and neutrophil elastase were measured once before and several times after cardiopulmonary bypass. The levels were compared between patients who experienced in-hospital adverse events or not, and between patients who experienced major adverse cardiac or cerebrovascular events (MACCEs) during three-year follow-up or not.
Results. Of the 244 patients enrolled, in-hospital adverse events occurred in 38 (15.6 %); of the 237 patients who completed follow-up, MACCEs occurred in 30 (12.7 %). Surgery led to significant increases in levels of all three pro-inflammatory factors, with levels returning to pre-bypass baseline on arrival in the intensive care unit (TNF-α), 4 h after arrival (interleukin-8) or 20 h after arrival (neutrophil elastase). However, pre- and post-bypass levels of all three factors did not differ significantly between patients who experienced adverse events in-hospital or not, or between patients who experienced MACCEs during follow-up or not.
Conclusions. Levels of TNF-α, interleukin-8 and neutrophil elastase may not be associated with poor prognosis after cardiopulmonary bypass. This may help explain why “cytokine clearance” strategies fail to improve clinical outcomes after on-pump cardiac surgery.

1. Squiccimarro E, Labriola C, Malvindi PG, Margari V, Guida P, Visicchio G et al. Prevalence and Clinical Impact of Systemic Inflammatory Reaction After Cardiac Surgery. Journal of Cardiothoracic and Vascular Anesthesia. 2019;33(6):1682–90. DOI: 10.1053/j.jvca.2019.01.043

2. MacCallum NS, Finney SJ, Gordon SE, Quinlan GJ, Evans TW. Modified Criteria for the Systemic Inflammatory Response Syndrome Improves Their Utility Following Cardiac Surgery. Chest. 2014;145(6):1197–203. DOI: 10.1378/chest.13-1023

3. Warren OJ, Watret AL, De Wit KL, Alexiou C, Vincent C, Darzi AW et al. The Inflammatory Response to Cardiopulmonary Bypass: Part 2–Anti-Inflammatory Therapeutic Strategies. Journal of Cardiothoracic and Vascular Anesthesia. 2009;23(3):384–93. DOI: 10.1053/j.jvca.2008.09.007

4. Warren OJ, Smith AJ, Alexiou C, Rogers PLB, Jawad N, Vincent C et al. The Inflammatory Response to Cardiopulmonary Bypass: Part 1–Mechanisms of Pathogenesis. Journal of Cardiothoracic and Vascular Anesthesia. 2009;23(2):223–31. DOI: 10.1053/j.jvca.2008.08.007

5. Gao M, Xie B, Gu C, Li H, Zhang F, Yu Y. Targeting the proinflammatory cytokine tumor necrosis factor-α to alleviate cardiopulmonary bypass-induced lung injury (Review). Molecular Medicine Reports. 2015;11(4):2373–8. DOI: 10.3892/mmr.2014.3050

6. Ayıkgöz Y, Salih Aydın M, Kankılıç N, Temiz E. Nuclear factor erythroid 2-related factor 2 (Nrf2), tumor necrosis factor alpha protein (TNF-α), heme oxygenase-1 (HO-1) gene expressions during cardiopulmonary bypass. Gene. 2021;790:145690. DOI: 10.1016/j.gene.2021.145690

7. Trop S, Marshall JC, Mazer CD, Gupta M, Dumont DJ, Bourdeau A et al. Perioperative cardiovascular system failure in South Asians undergoing cardiopulmonary bypass is associated with prolonged inflammation and increased Toll-like receptor signaling in inflammatory monocytes. Journal of Surgical Research. 2014;187(1):43–52. DOI: 10.1016/j.jss.2013.09.035

8. Zhao P, Lieu T, Barlow N, Sostegni S, Haerteis S, Korbmacher C et al. Neutrophil Elastase Activates Protease-activated Receptor-2 (PAR2) and Transient Receptor Potential Vanilloid 4 (TRPV4) to Cause Inflammation and Pain. Journal of Biological Chemistry. 2015;290(22):13875–87. DOI: 10.1074/jbc.M115.642736

9. Kotani N, Hashimoto H, Sessler DI, Muraoka M, Wang J-S, O’Connor MF et al. Neutrophil Number and Interleukin-8 and Elastase Concentrations in Bronchoalveolar Lavage Fluid Correlate with Decreased Arterial Oxygenation After Cardiopulmonary Bypass. Anesthesia & Analgesia. 2000;90(5):1046–51. DOI: 10.1097/00000539-200005000-00009

10. Jarczak D, Nierhaus A. Cytokine Storm–Definition, Causes, and Implications. International Journal of Molecular Sciences. 2022;23(19):11740. DOI: 10.3390/ijms231911740

11. Becker S, Lang H, Vollmer Barbosa C, Tian Z, Melk A, Schmidt BMW. Efficacy of CytoSorb®: a systematic review and meta-analysis. Critical Care. 2023;27(1):215. DOI: 10.1186/s13054-023-04492-9

12. Liu M-H, Yu H, Zhou R-H. Application of Adsorptive Blood Purification Techniques during Cardiopulmonary Bypass in Cardiac Surgery. Oxidative Medicine and Cellular Longevity. 2022;2022:6584631. DOI: 10.1155/2022/6584631

13. Magoon R, Loona M, Kaur Kohli J, Kashav R. Cytokine Adsorption in Cardiac Surgery: where do we stand? Brazilian Journal of Cardiovascular Surgery. 2020;35(3):XV–XVI. DOI: 10.21470/1678-9741-2019-0480

14. Baumann A, Buchwald D, Annecke T, Hellmich M, Zahn PK, Hohn A. RECCAS - REmoval of Cytokines during CArdiac Surgery: study protocol for a randomised controlled trial. Trials. 2016;17(1):137. DOI: 10.1186/s13063-016-1265-9

15. Garau I, März A, Sehner S, Reuter DA, Reichenspurner H, Zöllner C et al. Hemadsorption during cardiopulmonary bypass reduces interleukin 8 and tumor necrosis factor α serum levels in cardiac surgery: a randomized controlled trial. Minerva Anestesiologica. 2019;85(7):715–23. DOI: 10.23736/S0375-9393.18.12898-7

16. Liu C, Yang Y, Du L, Chen S, Zhang J, Zhang C et al. Platelet-leukocyte aggregate is associated with adverse events after surgical intervention for rheumatic heart disease. Scientific Reports. 2019;9(1):13069. DOI: 10.1038/s41598-019-49253-3

17. Yang S, Huang X, Liao J, Li Q, Chen S, Liu C et al. Platelet-leukocyte aggregates – a predictor for acute kidney injury after cardiac surgery. Renal Failure. 2021;43(1):1155–62. DOI: 10.1080/0886022X.2021.1948864

18. Khalil AA, Hall JC, Aziz FA, Price P. Tumour necrosis factor: implications for surgical patients. ANZ Journal of Surgery. 2006;76(11):1010–6. DOI: 10.1111/j.1445-2197.2006.03921.x

19. Neuschäfer-Rube F, Pathe-Neuschäfer-Rube A, Hippenstiel S, Püschel GP. PGE2 enhanced TNFα-mediated IL-8 induction in monocytic cell lines and PBMC. Cytokine. 2019;113:105–16. DOI: 10.1016/j.cyto.2018.06.020

20. Ghasemi H, Ghazanfari T, Yaraee R, Faghihzadeh S, Hassan ZM. Roles of IL-8 in Ocular Inflammations: A Review. Ocular Immunology and Inflammation. 2011;19(6):401–12. DOI: 10.3109/09273948.2011.618902

21. Márquez EJ, Chung C, Marches R, Rossi RJ, Nehar-Belaid D, Eroglu A et al. Sexual-dimorphism in human immune system aging. Nature Communications. 2020;11(1):751. DOI: 10.1038/s41467-020-14396-9

22. Huang Z, Chen B, Liu X, Li H, Xie L, Gao Y et al. Effects of sex and aging on the immune cell landscape as assessed by single-cell transcriptomic analysis. Proceedings of the National Academy of Sciences. 2021;118(33):e2023216118. DOI: 10.1073/pnas.2023216118